Back

Prevalence and prognostic impact of tricuspid regurgitation following LAD and LCX related STEMI

31 August 2026 (08:15 - 08:45)
Organised by: Logo
Congress Presentation Part of: Prognostication in patients with acute coronary syndrome ST-Elevation Myocardial Infarction (STEMI) ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Katia Orvin

Rabin Medical Centre, Petah Tikva (Israel)

4 More presentations in this session

Presentation thumbnail
Primary angioplasty in Portugal during the stent for life / stent save a life initiative: where do we stand?
Doctor C. Martins (Almada, PT)
Abstract Slides Video
Presentation thumbnail
Resistive reserve ratio (RRR) predicts myocardial metabolic recovery in the acute phase of takotsubo syndrome: a pilot study
Doctor Y. Nishimura (Kochi, JP)
Abstract Slides Video
Presentation thumbnail
Impact of beta-blockers on long-term mortality in takotsubo syndrome
Doctor M. Kitagawa (Chiba, JP)
Abstract Slides Video
Presentation thumbnail
Patterns and trajectories of long-term trajectory of blood pressure in patients with acute myocardial infarction and heart failure
Doctor Y. Ohnaga (Chiba, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Prognostication in patients with acute coronary syndrome

The Event

Event poster

ESC Congress 2026

31 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic value of right ventricular diastolic dysfunction in patients with inferior ST elevated myocardial infarction
29 August 2022
thumbnail
Congress Presentation
Tricuspid regurgitation after cardiac transplantation. Multicenter epidemiological study.
29 June 2021
thumbnail
Congress Presentation
Clinical impact of secondary tricuspid regurgitation in patients following acute myocardial infarction
30 August 2025
thumbnail
Congress Presentation
Prognostic impact of left circumflex artery as the culprit lesion in STEMI: short- and long-term survival analysis
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources